Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Frydman

Ariel Ernesto Frydman, Petachtikva IL

Patent application numberDescriptionPublished
20110283101System to Enable Detecting Attacks Within Encrypted Traffic - A system and method for detecting network attacks within encrypted network traffic received by a protected network includes a decryption module and an adaptor module. This system and method can be inserted and used with multiple types of operating systems.11-17-2011

Benjamin Frydman, Madison, WI US

Patent application numberDescriptionPublished
20090143456Polyamine Analogs as Modulators of Cell Migration and Cell Motility - This disclosure relates to methods of inhibiting cell motility or cell migration, and of treating diseases involving cell migration or cell motility, using polyamine analogs, such as conformationally restricted polyamine analogs. The diseases to be treated include immune disorders, inflammatory conditions, infection, abnormal immune responses, undesired angiogenesis, tumor cell metastasis or invasion, atherosclerosis, vascular graft occlusion, transplant rejection, other complications of transplants, glomerulonephritis, arthritis, inflammatory responses subsequent to stroke or ischemia, and asthma.06-04-2009
20090275664NOVEL POLYAMINE ANALOG CONJUGATES AND QUINONE CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES - Peptide conjugates in which cytocidal and cytostatic agents, such as polyamine analogs or naphthoquinones, are conjugated to a polypeptide recognized and cleaved by enzymes such as prostate-specific antigen (PSA) and cathepsin B are provided, as well as compositions comprising these conjugates. Methods of using these conjugates in the treatment of prostate diseases are also provided.11-05-2009

Patent applications by Benjamin Frydman, Madison, WI US

Benjamin Frydman US

Patent application numberDescriptionPublished
20090124832OLIGOAMINE COMPOUNDS AND DERIVATIVES THEREOF FOR CANCER THERAPY - Oligoamine compounds with anti-cancer and anti-proliferative activity are provided, as well as methods for making and using the compounds. The compounds are shown to be active against prostate cancer cell lines and against prostate cancer tumors in mice. The compounds are also useful in treatment of breast cancer and other cancers.05-14-2009

Daniel Frydman, Haifa IL

Patent application numberDescriptionPublished
20100262749Communication Processor Board - A signal processing board including a resource board substrate, an external interface on the board substrate, adapted to receive signals for processing, at least one slot adapted to receive a plug-in module with at least one processor thereon and an interface unit adapted to at least participate in converting signals exchanged between the external interface and a processor on a module received by the slot, between a format of signals received by the external interface and a signal format of the processor. The interface unit is suitable to at least participate in the conversion for a plurality of types of processors that differ in the format in which they transmit or receive signals.10-14-2010

Daniel Nathan Frydman, Haifa IL

Patent application numberDescriptionPublished
20110013631SYSTEM AND METHOD FOR EFFICIENT DELIVERY OF MULTI-UNICAST COMMUNICATION TRAFFIC - Disclosed is a system and method for the delivery of multi-unicast communication traffic. A multimedia router is adapted to analyze and identify contents which it handles and one or more access nodes are adapted to receive one or more of the identified contents, cache contents based on said identification; and use cached contents as substitutes for redundant traffic, received by the same access node.01-20-2011

Iian Frydman, Rehovot IL

Patent application numberDescriptionPublished
20110217082ELECTROPHOTOGRAPHIC PRINTING - Electrophotographic printing apparatus and method of printing using electrophotographic printing apparatus, the apparatus comprising an image-forming member having a surface on which a latent electrostatic image can be formed and developed for transfer of the developed image to a substrate via an intermediate transfer member. The apparatus comprises a voltage supply for generating electric potential between the surface of the intermediate transfer member and the image-forming member such that the developed image formed on the surface of the image-forming member is transferred to the intermediate transfer member. A controller of the apparatus controls the voltage supply to adjust the electrical potential to affect the transfer of ink to the intermediate transfer member from the image-forming member. In this way, the apparatus can adjust for changes in the electrical properties of the intermediate transfer member.09-08-2011

Ilan Frydman, Rishon Le Zion IL

Patent application numberDescriptionPublished
20100288146AUTOMATIC ADJUSTMENT OF PRINTER DRUM SPACING - A method is presented for automatically controlling the spacing between printer drums. The printer includes at least two print drums (11-18-2010

Ilan Frydman, Tel Aviv, IL US

Patent application numberDescriptionPublished
20080267660Apparatus And Method For Driving A Machine In A Replaceable Cartridge - An apparatus for driving a machine in a replaceable cartridge, the cartridge supporting a first rotatable element for transferring rotary motion to the machine, includes a housing for accommodating the cartridge at a pre-determined position. A second rotatable element is supported in the housing. A locking mechanism includes a component, provided on a certain one of the first and second rotatable elements, and capable of assuming a state of readiness in which, with the cartridge at the pre-determined position, the component is positioned relative to the other of the rotatable elements such that, upon rotation of the second rotatable element in at least a first direction, the first rotatable element rotates with the second rotatable element, and in which state the first and second rotatable elements are axially decoupled. The certain one of the first and second rotatable elements is provided with a mechanism for exerting a torque on the component tending to establish the state of readiness.10-30-2008

Ilan Frydman, Tel Aviv IL

Patent application numberDescriptionPublished
20110120331IMAGE TRANSFER BLANKETS FOR PRINTING APPARATUSES - An image transfer blanket for use in a printing apparatus. In one embodiment, the blanket includes an inner layer and an outer layer that overlies the inner layer and that defines an outer surface from which an ink image can be transferred to a print medium, the outer layer not bonded to the inner layer to enable removal and replacement of the outer layer independent of the inner layer.05-26-2011

Judith Frydman, Stanford, CA US

Patent application numberDescriptionPublished
20100093824METHODS OF TREATING VIRAL INFECTION - The present invention provides methods of treating an RNA viral infection, generally involving administering an agent that reduces the activity of a host cell protein required for maturation of a viral protein, where the emergence of variant virus resistant to the agent is reduced. The present invention further provides combination therapies for viral infection, involving administration of two or more agents that reduce the activity of a host cell protein required for maturation of a viral protein.04-15-2010

Larry G. Frydman, Toronto CA

Patent application numberDescriptionPublished
20110162146Therapeutic support pillow - The present invention is directed to a pillow including a top layer, a middle layer and a bottom layer. The top layer includes a front neck supporting buttress, a back neck supporting buttress and a cavity connecting the front neck supporting buttress and the back neck supporting buttress. The cavity is configured to accommodate a facial mask. The middle layer is connectable to the top layer and includes at least two inserts. Removal of at least one of the inserts provides for customized angulations of the pillow. The bottom layer is connectable to one of the top layer or the middle layer.07-07-2011

Lucio Frydman, Rehovot IL

Patent application numberDescriptionPublished
20100001727METHOD AND APPARATUS FOR ACQUIRING HIGH RESOLUTION SPECTRAL DATA OR HIGH DEFINITION IMAGES IN INHOMOGENEOUS ENVIRONMENTS - A method and apparatus for treating a sample for acquiring high-definition magnetic resonance images (MRI images) or high resolution nuclear magnetic resonance (NMR) spectra even in the presence of magnetic field distortions within one or multiple scans. The spatial nature and temporal dependence of the field inhomogeneities are determined a priori using any of several literature procedures. A static or oscillating magnetic field gradient is applied on the sample so as to endow spins at different positions within the sample with different resonance frequencies. A phase- and amplitude-modulated radiofrequency (RF) pulse is applied in unison with the magnetic field gradient so as to endow spins at different positions within the sample with a homogeneous excitation/inversion profile. The nature of the spatially-selective RF irradiation is tailored in such a way that, when added on top of the effects of the inhomogeneities, the spins' evolution phases and their signal amplitudes at the time of the acquisition become independent of the inhomogeneities. The spin signals thus created are captured and decoded, so as to obtain the spins' response as if the inhomogeneity was not present. The collected data is processed to a suitable rearrangement and Fourier analysis procedure to retrieve a final undistorted image or spectrum. The magnetic field gradient can be oscillated to impose this kind of inhomogeneity corrections on multiple spatial dimensions sequentially, or simultaneously.01-07-2010

Rene Frydman, Paris FR

Patent application numberDescriptionPublished
20110306547LHRH - ANTAGONISTS IN THE TREATMENT OF FERTILITY DISORDERS - A method of treating infertility disorders by 1) administering an LH-RH antagonist, preferably Cetrorelix, in amounts to selectively suppress endogenous LH but not FSH secretion and 2) inducing follicle growth by administration of exogenous gonadotropin. The selective suppression OF LH allows FSH secretion to be at natural level S thereby not affecting individual estrogen development. The LH-RH antagonist can be given as a single or dual subcutaneous dose in the range of 1 mg to 10 mg, preferably 2 mg-6 mg. In multiple dosing posology, LH-RH antagonist can be administered subcutaneously in an amount in the range of 0.1 to 0.5 mg of LH-RH antagonist/day . LH-RH antagonist is applied starting cycle day 1 to 10, preferably on day 4 to 8, and ovulation can be induced between day 9 and 20 of the menstruation cycle by administering rec. LH, native LH-RH, LH-RH agonist or by HCG. In addition rec. LH, native LH-RH or LH-RH agonist can be given to avoid hyperstimulation syndrome and native LH-RH or a LH-RH agonist can be administered to avoid luteal phase stimulation by neutralising the negative effects of HCG.12-15-2011

Veronica Frydman, Rechovot IL

Patent application numberDescriptionPublished
20080305964Single-Step Platform for On-Chip Integration of Bio-Molecules - Novel compounds having a functionalized group capable of binding to a solid substrate; a photoactivatable group capable of generating a reactive group upon exposure to light and being for binding a screenable moiety; and a polymer capable of forming a monolayer on a solid substrate, and having the functionalized group and to the photoactivatable group attached thereto and processes for the preparation thereof are disclosed. Further disclosed are arrays of screenable moieties (e.g., nucleic acids, proteins, carbohydrates, substrates, chelating agents and many more) prepared using these novel compounds.12-11-2008

Veronica Frydman, Rehovot IL

Patent application numberDescriptionPublished
20100069478ISOFLAVONE DERIVATIVES AND USES THEREOF - Isoflavone derivatives are provided comprising a carboxyalkylene moiety linked via its alkylene chain to the aromatic ring and via its carboxy group to an aminoalkyleneamino residue, which, in turn, is covalently linked to a functional group B. The isoflavone derivatives are preferably derived from biochanin A, genistein, and daidzein, and the functional group B is preferably an amino protecting group. These isoflavone derivatives are useful for treating or preventing diseases or disorders associated with estrogen receptor functioning.03-18-2010